Fumihiro Kashizaki

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 23, 2022
Efficacy of lorlatinib after alectinib-induced interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small cell lung cancer: a case report.

Fumihiro Kashizaki, Arihito Tanaka, Yasutomo Sekido

Pageof 1

Frequent Collaborators